Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance
Clinical trial NCT05704621 · RECRUITING
Trial details
- NCT number
- NCT05704621
- Sponsor
- Korea University Guro Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2026-12-28
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.